Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
NCT ID: NCT01361685
Last Updated: 2021-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
366 participants
OBSERVATIONAL
2011-05-31
2021-02-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361672
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
NCT00930904
Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study
NCT02294331
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
NCT00869921
Model 4396 Left Ventricular (LV) Lead Study
NCT00853593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient has or is intended to receive an Attain Ability Model 4396 LV lead
* Patient within 30 day post implant enrollment window
Exclusion Criteria
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southwest EP Clinic
Gilbert, Arizona, United States
Saint Vincent Heart Clinic Arkansas
Little Rock, Arkansas, United States
Eisenhower Desert Cardiology Center
Rancho Mirage, California, United States
COR Healthcare
Torrance, California, United States
Cardiovascular Consultants Medical Group
Van Nuys, California, United States
Colorado Heart and Vascular, PC
Lakewood, Colorado, United States
Yale University
New Haven, Connecticut, United States
MedStar Southern Maryland Hospital Center
Washington D.C., District of Columbia, United States
Bradenton Cardiology
Bradenton, Florida, United States
Baptist Heart Specialists
Jacksonville, Florida, United States
Indiana University Health - Methodist Research Institute
Indianapolis, Indiana, United States
Iowa Heart Center
West Des Moines, Iowa, United States
Louisville Cardiology Group
Louisville, Kentucky, United States
Cenla Heart Specialists
Alexandria, Louisiana, United States
Our Lady of the Lake Office of Research
Baton Rouge, Louisiana, United States
Michigan Heart
Ypsilanti, Michigan, United States
Metropolitan Cardiology Consultants PA
Coon Rapids, Minnesota, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, United States
North Memorial Heart and Vascular Institute
Robbinsdale, Minnesota, United States
HealthCare Partners Medical Group
Saint Louis Park, Minnesota, United States
Saint Lukes Health System
Kansas City, Missouri, United States
Washington University
St Louis, Missouri, United States
Patients First Health Care LLC
Washington, Missouri, United States
New Jersey Cardiology Associates
West Orange, New Jersey, United States
Presbyterian Heart Group
Albuquerque, New Mexico, United States
NYU Langone Medical Center
New York, New York, United States
New York-Presbyterian Hospital/Columbia University Medical Center
New York, New York, United States
New York-Presbyterian Hospital/Weill Cornell Medical Center
New York, New York, United States
Central New York Cardiology
Utica, New York, United States
WakeMed Health & Hospitals
Raleigh, North Carolina, United States
The Christ Hospital Health Network
Cincinnati, Ohio, United States
University of Cincinnati
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Lehigh Valley Health Network
Bethlehem, Pennsylvania, United States
Medicor Associates
Erie, Pennsylvania, United States
Lancaster General Hospital
Lancaster, Pennsylvania, United States
Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania, United States
Wellmont CVA Heart Institute
Kingsport, Tennessee, United States
Saint Thomas Research Institute
Nashville, Tennessee, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
Baylor Research Institute
Dallas, Texas, United States
Houston Methodist Hospital
Houston, Texas, United States
Baylor Research Institute
Plano, Texas, United States
STAR Clinical Trials
San Antonio, Texas, United States
EP Heart LLC
The Woodlands, Texas, United States
The University of Vermont Medical Center
Burlington, Vermont, United States
Aurora Cardiovascular Services
Milwaukee, Wisconsin, United States
Queen's University & Kingston General Hospital
Kingston, Ontario, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM) Hopital Hotel-Dieu
Montreal, Quebec, Canada
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)
Québec, , Canada
Universitatsklinikum Ulm
Ulm, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4396 Chronic Performance
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.